中国工程院院士董家鸿:医疗创新必须注重应用

2018-05-21 张鹏俊 张思玮 科学网

5月19日,由清华大学附属北京清华长庚医院与以色列富创(Messila)学院共同主办的医疗创业加速器峰会在北京召开。来自中以双方医药领域创新创业尖端人士与机构,分别结合医疗器械、肿瘤生物以及智慧医疗等热点话题进行了分享与讨论。

5月19日,由清华大学附属北京清华长庚医院与以色列富创(Messila)学院共同主办的医疗创业加速器峰会在北京召开。来自中以双方医药领域创新创业尖端人士与机构,分别结合医疗器械、肿瘤生物以及智慧医疗等热点话题进行了分享与讨论。

医药卫生领域的科技创新和成果转化关系全民的健康,是实现健康中国的重要战略。而我国医疗行业却面临中低端仿制产品居多、重要医疗设备依赖于进口的局面。这对我们的创新教育提出了巨大的挑战。

“为推动学科交融及临床转化科学研究,清华大学临床医学院主要采取了两方面行动,一是组建医理工结合、医研企融合的临床转化科学平台和创新联盟,推出临床转化科学的‘BBC’模式,即从临床到实验室到客户,打造以临床问题为引擎、市场需求为导向的健康科技创新体系;二是建立学术型医师的科学、合理、公正的评价机制和标准,倡导和激励以解决临床实际问题为导向的研究。医疗创新必须注重应用,注重创新成果的市场转化,而以色列创新创业的成功经验非常值得借鉴。”中国工程院院士、清华大学临床医学院院长、北京清华长庚医院执行院长董家鸿说。

以色列被称为“创业之国”,不仅涌现出6000多家科技初创企业,纳斯达克上市企业数量超过欧洲,科技产业贡献超过GDP的90%,而且凭借在遗传学、计算机科学、化学等领域的深耕,已有多达10名以色列人和以色列裔人获得过诺贝尔奖。而以色列富创学院作为一家医疗创业学院,一直致力于医疗创新教育理念和企业创业经验的传播。

借此次峰会召开之际,北京清华长庚医院积极地探索与以色列富创学院合作培养医疗创新人才,通过共同设计医药创业课程等方式,为医学生、医疗保健系统内从业人士,提供生物医学创新、创业项目规划、建立、管理和推广的培训教育。

据悉,诺贝尔化学奖获得者、以色列海法理工大学技术创业课程开创者丹·谢德曼教授,北京市医管局、北京市卫生计生委相关领导出席了此次峰会。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1741156, encodeId=2b791e411561a, content=<a href='/topic/show?id=108734851ea' target=_blank style='color:#2F92EE;'>#医疗创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34851, encryptionId=108734851ea, topicName=医疗创新)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=02e734877294, createdName=ms24272190615788285182, createdTime=Sun Feb 24 23:02:00 CST 2019, time=2019-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1688153, encodeId=f2f8168815345, content=<a href='/topic/show?id=6a8d4e950d4' target=_blank style='color:#2F92EE;'>#工程院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47950, encryptionId=6a8d4e950d4, topicName=工程院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b96328479830, createdName=ms5439512287675881, createdTime=Fri Apr 05 04:02:00 CST 2019, time=2019-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285576, encodeId=7e1d12855e6fd, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Wed May 23 01:02:00 CST 2018, time=2018-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1500849, encodeId=acf715008496c, content=<a href='/topic/show?id=ccc42182eab' target=_blank style='color:#2F92EE;'>#中国工程院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21827, encryptionId=ccc42182eab, topicName=中国工程院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc939466478, createdName=wumeihua91, createdTime=Wed May 23 01:02:00 CST 2018, time=2018-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1626370, encodeId=8c1d16263e03d, content=<a href='/topic/show?id=84f7882931a' target=_blank style='color:#2F92EE;'>#董家鸿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88293, encryptionId=84f7882931a, topicName=董家鸿)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3d121003748, createdName=bnjfx@133.com, createdTime=Wed May 23 01:02:00 CST 2018, time=2018-05-23, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1741156, encodeId=2b791e411561a, content=<a href='/topic/show?id=108734851ea' target=_blank style='color:#2F92EE;'>#医疗创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34851, encryptionId=108734851ea, topicName=医疗创新)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=02e734877294, createdName=ms24272190615788285182, createdTime=Sun Feb 24 23:02:00 CST 2019, time=2019-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1688153, encodeId=f2f8168815345, content=<a href='/topic/show?id=6a8d4e950d4' target=_blank style='color:#2F92EE;'>#工程院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47950, encryptionId=6a8d4e950d4, topicName=工程院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b96328479830, createdName=ms5439512287675881, createdTime=Fri Apr 05 04:02:00 CST 2019, time=2019-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285576, encodeId=7e1d12855e6fd, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Wed May 23 01:02:00 CST 2018, time=2018-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1500849, encodeId=acf715008496c, content=<a href='/topic/show?id=ccc42182eab' target=_blank style='color:#2F92EE;'>#中国工程院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21827, encryptionId=ccc42182eab, topicName=中国工程院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc939466478, createdName=wumeihua91, createdTime=Wed May 23 01:02:00 CST 2018, time=2018-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1626370, encodeId=8c1d16263e03d, content=<a href='/topic/show?id=84f7882931a' target=_blank style='color:#2F92EE;'>#董家鸿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88293, encryptionId=84f7882931a, topicName=董家鸿)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3d121003748, createdName=bnjfx@133.com, createdTime=Wed May 23 01:02:00 CST 2018, time=2018-05-23, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1741156, encodeId=2b791e411561a, content=<a href='/topic/show?id=108734851ea' target=_blank style='color:#2F92EE;'>#医疗创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34851, encryptionId=108734851ea, topicName=医疗创新)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=02e734877294, createdName=ms24272190615788285182, createdTime=Sun Feb 24 23:02:00 CST 2019, time=2019-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1688153, encodeId=f2f8168815345, content=<a href='/topic/show?id=6a8d4e950d4' target=_blank style='color:#2F92EE;'>#工程院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47950, encryptionId=6a8d4e950d4, topicName=工程院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b96328479830, createdName=ms5439512287675881, createdTime=Fri Apr 05 04:02:00 CST 2019, time=2019-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285576, encodeId=7e1d12855e6fd, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Wed May 23 01:02:00 CST 2018, time=2018-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1500849, encodeId=acf715008496c, content=<a href='/topic/show?id=ccc42182eab' target=_blank style='color:#2F92EE;'>#中国工程院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21827, encryptionId=ccc42182eab, topicName=中国工程院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc939466478, createdName=wumeihua91, createdTime=Wed May 23 01:02:00 CST 2018, time=2018-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1626370, encodeId=8c1d16263e03d, content=<a href='/topic/show?id=84f7882931a' target=_blank style='color:#2F92EE;'>#董家鸿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88293, encryptionId=84f7882931a, topicName=董家鸿)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3d121003748, createdName=bnjfx@133.com, createdTime=Wed May 23 01:02:00 CST 2018, time=2018-05-23, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1741156, encodeId=2b791e411561a, content=<a href='/topic/show?id=108734851ea' target=_blank style='color:#2F92EE;'>#医疗创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34851, encryptionId=108734851ea, topicName=医疗创新)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=02e734877294, createdName=ms24272190615788285182, createdTime=Sun Feb 24 23:02:00 CST 2019, time=2019-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1688153, encodeId=f2f8168815345, content=<a href='/topic/show?id=6a8d4e950d4' target=_blank style='color:#2F92EE;'>#工程院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47950, encryptionId=6a8d4e950d4, topicName=工程院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b96328479830, createdName=ms5439512287675881, createdTime=Fri Apr 05 04:02:00 CST 2019, time=2019-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285576, encodeId=7e1d12855e6fd, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Wed May 23 01:02:00 CST 2018, time=2018-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1500849, encodeId=acf715008496c, content=<a href='/topic/show?id=ccc42182eab' target=_blank style='color:#2F92EE;'>#中国工程院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21827, encryptionId=ccc42182eab, topicName=中国工程院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc939466478, createdName=wumeihua91, createdTime=Wed May 23 01:02:00 CST 2018, time=2018-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1626370, encodeId=8c1d16263e03d, content=<a href='/topic/show?id=84f7882931a' target=_blank style='color:#2F92EE;'>#董家鸿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88293, encryptionId=84f7882931a, topicName=董家鸿)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3d121003748, createdName=bnjfx@133.com, createdTime=Wed May 23 01:02:00 CST 2018, time=2018-05-23, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1741156, encodeId=2b791e411561a, content=<a href='/topic/show?id=108734851ea' target=_blank style='color:#2F92EE;'>#医疗创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34851, encryptionId=108734851ea, topicName=医疗创新)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=02e734877294, createdName=ms24272190615788285182, createdTime=Sun Feb 24 23:02:00 CST 2019, time=2019-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1688153, encodeId=f2f8168815345, content=<a href='/topic/show?id=6a8d4e950d4' target=_blank style='color:#2F92EE;'>#工程院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47950, encryptionId=6a8d4e950d4, topicName=工程院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b96328479830, createdName=ms5439512287675881, createdTime=Fri Apr 05 04:02:00 CST 2019, time=2019-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285576, encodeId=7e1d12855e6fd, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Wed May 23 01:02:00 CST 2018, time=2018-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1500849, encodeId=acf715008496c, content=<a href='/topic/show?id=ccc42182eab' target=_blank style='color:#2F92EE;'>#中国工程院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21827, encryptionId=ccc42182eab, topicName=中国工程院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc939466478, createdName=wumeihua91, createdTime=Wed May 23 01:02:00 CST 2018, time=2018-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1626370, encodeId=8c1d16263e03d, content=<a href='/topic/show?id=84f7882931a' target=_blank style='color:#2F92EE;'>#董家鸿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88293, encryptionId=84f7882931a, topicName=董家鸿)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3d121003748, createdName=bnjfx@133.com, createdTime=Wed May 23 01:02:00 CST 2018, time=2018-05-23, status=1, ipAttribution=)]

相关资讯

医疗创新的很大挑战:难脱路径依赖

囿于中国的医疗体制,建构于其上的医疗创新有着较强的路径依赖。这一路径依赖使得大部分医疗创新模式最终助推原有强势力量日益自我强化原有的发展逻辑,最终积重难返。

2014年医疗创新面面观——从2014国际消费电子展展望

    想了解2014年最新的可穿戴技术、最酷的3D打印技术以及最炫的数字医疗技术吗?2014 国际消费电子展会成为新兴创新实践体验基地。  “从可穿戴技术、最新的3D打印技术、物联网、无人驾驶汽车到传感器技术,2014国际消费电子展( International CES®,以下简称CES)将成为世界上最大的新兴创新实践体验基地,”国际CES兼CEA企业业务战略高级副总裁卡伦·